ArticleChembiochem : a European journal of chemical biology2026
Development of a C5-Azidoacetamide-Modified 4-Amino-2,3-Difluorosialic Acid Activity-Based Probe for Labeling of Influenza A Neuraminidases.
Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Influenza A virus neuraminidase (NA) is central to the viral life cycle and a key target for studying sialoside recognition and hydrolysis and its impact on viral uptake, tropism, and pathogenesis. Here, we report the design, synthesis, and evaluation of 2,3-difluorosialic acid-based activity-based probes for NA profiling. The probes carry a C4-amino substituent to promote active-site engagement and stabilize covalent trapping through a tyrosine-sialosyl intermediate. A C5 azidoacetamide handle enables bioorthogonal tagging by CuAAC for detection, while a preclicked biotin variant supports one-step labeling. We synthesized both the azide and biotin formats and assessed their inhibitory activity against recombinant influenza A NAs. A reactivation assay showed prolonged, hour-scale recovery relative to related 2,3-difluoro analogs, although the C5 modification reduced NA affinity and covalent half-life compared with 4-amino-2,3-difluoro-Neu5Ac. In labeling experiments, the probes tagged multiple recombinant viral neuraminidases and NA present in virus samples. In addition, 9-azido-2,3-difluoro-Neu5Ac and its biotin preclicked counterpart proved potent activity-based probes for NAs. Together, these four probes provide lead structures for further development of molecular tools for cellular profiling, viral NA activity detection, and diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.